A new weapon in the war against opioid abuse?
What if local anesthesia didn't wear off after surgery? Or at least not for three or four days. That's a concept San Diego's Heron Therapeutics is moving into Phase 3 trials this year, with its long-acting and potentially opioid-sparing formulation.